Skip to main content

Opioid MDL: U.K.-Based Pharmaceutical Co. To Pay $24M

Opioid MDL: U.K.-Based Pharmaceutical Co. To Pay $24M

Opioid MDL: U.K.-Based Pharmaceutical Co. To Pay $24M

Introduction

On Friday 6, Mallinckrodt, a U.K. based pharmaceutical company, said that it would pay $24 million and donate up to $6 million in generic drugs to two Ohio counties to resolve their claims in the upcoming October 21 trial over the opioid crisis.

The drugmaker said the settlement was announced in principle with Cuyahoga and Summit counties over the allegations that the defendants fueled the opioid epidemic with a breakneck sales of painkillers and by underplaying the drugs' addiction risks. Both the counties will get much-needed support in the ongoing response to the opioid crisis as well as will get protection in any future insolvency proceeding by Mallinckrodt if the agreement is approved.

U.S. District Judge Dan Aaron Polster overseeing the opioid multidistrict litigation said that "a jury will decide whether, under Ohio law, the opioid epidemic constitutes an "ongoing public nuisance," finding that underlying factual issues must first be determined at trial."

Cuyahoga and Summit counties, seeking several billion dollars to cope with the opioid epidemic's effects, had asked the court to award them partial summary judgment arguing that no reasonable fact-finder could determine the underlying factual issues. However, the motion was denied by Judge Polster on September 4, stating that it was a question that must wait till the full airing of facts at trial.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!